Quarterly Result30 May 2026, 08:21 pm
Aarey Drugs FY26: Revenue ₹473.94 Mn, PAT ₹3.96 Mn
AI Summary
Aarey Drugs & Pharmaceuticals Ltd's board approved the audited standalone financial results for the fourth quarter and year ended March 31, 2026. The company reported revenue from operations of ₹473.94 million and a profit of ₹3.96 million for the year ended March 31, 2026. The board meeting, which commenced at 5:00 P.M. and concluded at 7:20 P.M., also approved a statement of deviation or variation in utilization of funds raised through convertible warrants.
Key Highlights
- Aarey Drugs' board approved audited standalone financial results for FY26.
- FY26 revenue from operations stood at ₹473.94 million.
- The company reported a profit of ₹3.96 million for FY26.
- The board approved a statement on the utilization of funds from convertible warrants.
- Trading window will open 48 hours after the announcement of results.
Price Impact
More from AREYDRG